Gastrointestinal stromal tumors and additional neoplasms

Dar’ya A. Filonenko; O. B Abukhaidar; K. A Vorontsova; N. T Tsymgitova; A. A Meshcheryakov

doi:10.17816/onco40200

Russian Journal of Oncology ›› 2015, Vol. 20 ›› Issue (6) :22 -27. DOI: 10.17816/onco40200

Articles

research-article

Gastrointestinal stromal tumors and additional neoplasms

Author information +

History +

PDF

Abstract

Gastrointestinal stromal tumors (GIST) are reported to occur in association with other secondary neoplasms. It is necessary to exclude other malignancies in case of non-typical GIST metastases pattern. Most common additional malignancies are urogenital and colorectal cancer. Article presents a clinical case report of two synchronous malignant tumors: GIST and kidney cancer.

Keywords

gastrointestinal stromal tumors / kidney cancer / additional malignancies / imatinib / sunitinib

Cite this article

Download citation ▾

Dar’ya A. Filonenko, O. B Abukhaidar, K. A Vorontsova, N. T Tsymgitova, A. A Meshcheryakov. Gastrointestinal stromal tumors and additional neoplasms. Russian Journal of Oncology, 2015, 20(6): 22-27 DOI:10.17816/onco40200

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Kalmár K., Tornóczky T., Pótó L., Illényi L., Kalmár Nagy K., Kassai M. et al. Gastrointestinal stromal tumours in a single institute: is there an association to other gastrointestinal malignancies? Magy. Seb. 2004; 57: 251-6.

[2]	Pandurengan R.K., Dumont A.G., Araujo D.M., Ludwig J.A., Ravi V., Patel S. et al. Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann. Oncol. 2010; 21: 07-11.

[3]	Agaimy A., Wuensch P.H Gastrointestinal stromal tumours in patientswith other-type cancer: a mere coincidence or an etiological association? A study of 97 GIST cases. Z. Gastroenterol. 2005; 43: 1025-30.

[4]	Ruka W., Rutkowski P., Nowecki Z., Nasierowska-Guttmejer A. Debiec-Rychter M. Other malignant neoplasms in patients with gastrointestinal stromal tumors (GIST). Med. Sci. Monit. 2004; 10: LE13-4.

[5]	Kövér E., Faluhelyi Z., Bogner B., Kalmár K., Horváth G., Tornóczky T.. Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms. Magy. Onkol. 2004; 48: 315-21.

[6]	Agaimy A., Wünsch P.H., Sobin L.H., Lasota J., Miettinen M. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin. Diagn. Pathol. 2006; 23: 120-9.

[7]	Vassos N., Agaimy A., Hohenberger W., Croner R.S. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: Prognostic implications. Int. J. Surg. 2014; 12: 371-7.

[8]	Мещеряков А.А., Цымжитова Н.Ц., Филоненко Д.А., Медведева Б.М.. Оценка эффективности таргетной терапии на примере клинического случая стромальной опухоли желудочно-кишечного тракта. Саркомы костей, мягких тканей и опухоли кожи. 2013; 2: 38-42.

[9]	Филоненко Д.А., Мещеряков А.А., Цыганова И.В., Мазуренко Н.Н. Эффективность терапии гливеком метастатических гастроинтестинальных стромальных опухолей в зависимости от локализации мутаций C-KIT и PDGFRA. Саркомы костей, мягких тканей и опухоли кожи. 2013; 4: 24-8.

[10]	Филоненко Д.А., Мещеряков А.А., Медведева Б.М., Анурова О.А., Степанова Е.В., Личиницер М.Р. Опыт применения гливека при злокачественных гастроинтестинальных стромальных опухолях. Фарматека. 2007; 18: 53-6.